Role of polyol pathway in nonenzymatic glycation

Nephrology Dialysis Transplantation

Volumn 11, Issue SUPPL. 5, 1996, Pages 95-98

  Hamada, Yoji ^a   Araki, Norie ^b   Horiuchi, Seikoh ^b   Hotta, Nigishi ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Advanced glycation end products; Erythrocyte; Non insulin dependent diabetes mellitus; Nonenzymatic glycation; Polyol pathway

Indexed keywords

ALDOSE REDUCTASE INHIBITOR; BOVINE SERUM ALBUMIN; DEOXYGLUCOSE; EPALRESTAT; FRUCTOSE 3 PHOSPHATE; GLYCOSYLATED PROTEIN; POLYOL;

CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; ERYTHROCYTE; GLYCATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0030512679     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/11.supp5.95     Document Type: Conference Paper

References (19)

1. Raskin P, Rosenstock J. Aldose reductase inhibitors and diabetic complications. Am J Med 1987; 83: 298-306
2. Hotta N, Sakamoto N. Aldose reductase inhibitors. In: Alberti KGMM, Krall LP, eds. The diabetes annual. Amsterdam, Elsevier, 1990; 330-361
3. Kinoshita JH, ML Satoh K, Dikmac E. Osmotic changes caused by accumulation of dulcitol in the lenses of rats fed with galactose. Nature 1962; 194: 1085-1087
4. Greene DA, Lattimer SA, Sima AA. Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med 1987; 316: 599-606
5. Williamson JR, Cheng K, Frangos M et al. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 1993; 42: 801-813
6. Cameron NE, Cotter MA. The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications. Diabetes/Metab Rev 1994; 10: 189-224
7. Suarez G, Rajaram R, Bhuyan KC, Oronsky AL, Goidl JA. Administration of an aldose reductase inhibitor induces a decrease of collagen fluorescence in diabetic rats. J Clin Invest 1988; 82: 624-627
8. Szwergold BS, Kappler F, Brown TR. Identification of fructose-3-phosphate in the lens of diabetic rats. Science 1990; 247: 451-454
9. Petersen A, Szwergold BS, Kappler F, Weingarten M, Brown TR. Identification of sorbitol 3-phosphate and fructose 3-phosphate in normal and diabetic human erythrocytes. J Biol Chem 1990; 265: 17424-17427
10. Lal S, Szwergold BS, Kappler F, Brown T. Detection of fructose-3-phosphokinase activity in intact mammalian lenses by 31P NMR spectroscopy. J Biol Chem 1993; 268: 7763-7767
11. Petersen A, Kappler F, Szwergold BS, Brown TR. Fructose metabolism in the human erythrocyte. Phosphorylation to fructose 3-phosphate. Biochem J 1992
12. Horiuchi S, Araki N, Morino Y. Immunochemical approach to characterize advanced glycation end products of the Maillard reaction. J Biol Chem 1991; 266: 7329-7332
13. Brownlee M, Vlassara H, Cerami A. Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann Intern Med 1984; 101: 527-537
14. Brownlee M. Glycation products and the pathogenesis of diabetic complications. Diabetes Care 1992; 15: 1835-43
15. Hammes HP, Martin S, Federlin K, Geisen K, Brownlee M. Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc Natl Acad Sci USA 1991; 88: 11555-11558
16. Soulis LT, Cooper M, Papazoglou D, Clarke B, Jerums G. Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic rat. Diabetes 1991; 40: 1328-1334
17. Yagihashi S, Kamijo M, Baba M, Yagihashi N, Nagai K. Effect of aminoguanidine on functional and structural abnormalities in peripheral nerve of STZ-induced diabetic rats. Diabetes 1992; 41: 47-52
18. Kato H, Hayase F, Shin DB, Oimomi M, Baba S. 3-Deoxyglucosone, an intermediate product of the Maillard reaction. Prog Clin Biol Res 1989; 304: 69-84
19. Hotta N, Kakuta H, Fukasawa H et al. Effects of a fructose-rich diet and the aldose reductase inhibitor, ONO-2235, on the development of diabetic neuropathy in streptozotocin-treated rats. Diabetologia 1985; 28: 176-180